Learn More
Patients with relapsed peripheral T-cell non-Hodgkin’s lymphoma (T-NHL) carry a particularly dismal prognosis, and although this lymphoma is often chemosensitive, optimal therapeutic strategies are(More)
Immunocompromised patients are at high risk of invasive fungal infections (IFI), in particular those with haematological malignancies undergoing remission-induction chemotherapy for acute myeloid(More)
BACKGROUND Allogeneic stem-cell transplantation has had limited success for patients with refractory and relapsed aggressive B-cell or T-cell lymphoma. We investigated the effect of adding rituximab(More)